GENIE Trademark

Trademark Overview

On Friday, May 8, 2020, a trademark application was filed for GENIE with the United States Patent and Trademark Office. The USPTO has given the GENIE trademark a serial number of 88908028. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, March 5, 2024. This trademark is owned by CELLTHEON CORPORATION. The GENIE trademark is filed in the Pharmaceutical Products category with the following description:

Gene therapy products, namely, genetically engineered cell lines for the production of recombinant viruses
genie

General Information

Serial Number88908028
Word MarkGENIE
Filing DateFriday, May 8, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, March 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 20, 2021

Trademark Statements

Goods and ServicesGene therapy products, namely, genetically engineered cell lines for the production of recombinant viruses

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 20, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCELLTHEON CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressUnion City, CA 94587
Party NameCELLTHEON CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressUnion City, CA 94587

Trademark Events

Event DateEvent Description
Wednesday, March 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 5, 2024SOU EXTENSION 5 GRANTED
Tuesday, March 5, 2024SOU EXTENSION 5 FILED
Tuesday, March 5, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 1, 2023SOU EXTENSION 4 GRANTED
Tuesday, August 1, 2023SOU EXTENSION 4 FILED
Tuesday, August 1, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, February 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 30, 2023SOU EXTENSION 3 GRANTED
Monday, January 30, 2023SOU EXTENSION 3 FILED
Monday, January 30, 2023SOU TEAS EXTENSION RECEIVED
Friday, August 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 10, 2022SOU EXTENSION 2 GRANTED
Wednesday, August 10, 2022SOU EXTENSION 2 FILED
Wednesday, August 10, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, February 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 14, 2022SOU EXTENSION 1 GRANTED
Monday, February 14, 2022SOU EXTENSION 1 FILED
Monday, February 14, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, September 14, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 20, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 30, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 14, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 14, 2021EXAMINER'S AMENDMENT ENTERED
Monday, June 14, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 14, 2021EXAMINERS AMENDMENT E-MAILED
Monday, June 14, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 2, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, June 2, 2021FINAL REFUSAL E-MAILED
Wednesday, June 2, 2021FINAL REFUSAL WRITTEN
Wednesday, May 5, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 5, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 30, 2021ASSIGNED TO LIE
Friday, January 15, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, August 9, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, August 9, 2020NON-FINAL ACTION E-MAILED
Sunday, August 9, 2020NON-FINAL ACTION WRITTEN
Tuesday, August 4, 2020ASSIGNED TO EXAMINER
Wednesday, May 20, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

genie lines production recombinant viruses cell engineered therapy products namely genetically